RESMED INC — Director's Dealing 2016

Oct 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-10-04

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-04	ResMed Common Stock	M	16085	$25.54	Acquired	364063	Direct
2016-10-04	ResMed Common Stock	M	2967	$33.70	Acquired	367030	Direct
2016-10-04	ResMed Common Stock	M	948	$33.70	Acquired	367978	Direct
2016-10-04	ResMed Common Stock	S	20000	$64.698	Disposed	347978	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-04	Resmed Stock Option Plan	$25.54	M	16085	Disposed	2016-12-17	ResMed Common Stock (16085)	Direct
2016-10-04	Resmed Stock Option Plan	$33.70	M	948	Disposed	2017-11-11	ResMed Common Stock (948)	Direct
2016-10-04	Resmed Stock Option Plan	$33.70	M	2967	Disposed	2017-11-11	ResMed Common Stock (2967)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from 64.32 to 65.20. The price reported above represents the weighted average sales price.

F3: Represents date options first became exercisable. Options vested 1/4 per year.